跳至主要内容
临床试验/NCT01562795
NCT01562795已完成不适用

Efficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye Disease

Wenzhou Medical University1 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2012年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
48
试验地点
1
主要终点
tear osmolarity

研究概览

简要总结

This clinical trial is to investigate whether nonsteroid anti-inflammatory drops have therapeutic effect on moderate to severe dry eye patients.And compare the efficacy of the two nonsteroid anti-inflammatory drops with topical corticosteroids.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • moderate to severe dry eye syndrome
  • tear film breakup time >0 second and ≤5 seconds,or schirmer test(no anaesthesia)≥2mm/5min and ≤5mm/5min
  • corneal staining≥3 scores

排除标准

  • allergic to any composition of the drugs under experiment
  • previous use of anti-inflammatory drugs or immunosuppressive agent
  • viral,bacterial or fungal infection of the eye
  • eyelid anomaly
  • glaucoma or high IOP
  • significant meibomian gland dysfunction

研究组 & 干预措施

group 1

Experimental

干预措施: nonsteroid anti-inflammatory drops (Drug)

group 2

Experimental

干预措施: nonsteroid anti-inflammatory drops (Drug)

group 3

Experimental

干预措施: corticosteroids (Drug)

group 4

Other

干预措施: artificial tear substitute (Drug)

结局指标

主要结局

tear osmolarity

时间窗: Day 0, Day 14

次要结局

  • corneal staining(0 day,7th day and 14th day after treatment)
  • Schirmer test(without anaesthesia)(0 day,7th day,14th day after treatment)
  • tear film breakup time(TBUT)(0 day,7th day and 14th day after treatment)
  • meibomian gland function(0 day,7th day and 14th day after treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Xiangtian Zhou

MD

Wenzhou Medical University

研究点 (1)

Loading locations...

相似试验